A newly identified bat coronavirus, HKU5-CoV-2, has been found in China, raising concerns about potential transmission to humans. The discovery was made by a team of virologists led by Shi Zhengli ...

From L-R, Garcia, Wahl and Battaglia Approximately 15 million to 20 million Americans who have acquired COVID-19 experience ...

New research reveals promising drug targets to block coronaviruses at multiple stages of infection—even across different ...

Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

The JN.1 subvariant of SARS-CoV-2 emerged in late 2023 and rapidly became dominant globally. In the past 6 months, JN.1 has continued to evolve, giving rise to multiple sublineages with unique spike ...

It is well-established that COVID-19 is a systemic disease. Besides the respiratory system, the virus can infect different ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...

A new study reveals how targeted electromagnetic waves can disrupt the SARS-CoV-2 spike protein, potentially opening doors to innovative disinfection and infection control strategies. Study: ...

Despite vaccines and treatments, SARS-CoV-2-the virus that causes COVID-19-continues to pose a global health threat, driven ...

In the article by Xie et al. (Aug. 8 issue) 1 regarding postacute sequelae of SARS-CoV-2 infection (PASC) in the pre-delta, delta, and omicron eras, the authors note that 71.89% of the decrease in ...